LOW ACTIVITY OF CIRCADIAN CONTINUOUS FLUORODEOXYURIDINE (FUDR) CHEMOTHERAPY IN POOR-PROGNOSIS METASTATIC RENAL-CANCER

  • Authors:
    • L MIGLIETTA
    • L CANOBBIO
    • D CANNATA
    • A CUROTTO
    • F BERTIRIBOLI
    • L GIULIANI
    • F BOCCARDO
  • View Affiliations

  • Published online on: January 1, 1994     https://doi.org/10.3892/or.1.1.121
  • Pages: 121-123
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Thirteen patients with progressive metastatic renal cell carcinoma were treated with circadian continuous Fluorodeoxyuridine (FUDR) infusions. The drug was delivered according to the variable rate infusion of Hrushesky protocol. All patients had previously received and failed systemic treatment and presented more than one metastatic site. The toxicity was low, however, no objective responses were observed. Despite previous reports of activity of FUDR in metastatic renal cancer, we suggest that the present regimen cannot be recommended in poor prognosis metastatic renal cancer.

Related Articles

Journal Cover

January 1994
Volume 1 Issue 1

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
MIGLIETTA L, CANOBBIO L, CANNATA D, CUROTTO A, BERTIRIBOLI F, GIULIANI L and BOCCARDO F: LOW ACTIVITY OF CIRCADIAN CONTINUOUS FLUORODEOXYURIDINE (FUDR) CHEMOTHERAPY IN POOR-PROGNOSIS METASTATIC RENAL-CANCER. Oncol Rep 1: 121-123, 1994
APA
MIGLIETTA, L., CANOBBIO, L., CANNATA, D., CUROTTO, A., BERTIRIBOLI, F., GIULIANI, L., & BOCCARDO, F. (1994). LOW ACTIVITY OF CIRCADIAN CONTINUOUS FLUORODEOXYURIDINE (FUDR) CHEMOTHERAPY IN POOR-PROGNOSIS METASTATIC RENAL-CANCER. Oncology Reports, 1, 121-123. https://doi.org/10.3892/or.1.1.121
MLA
MIGLIETTA, L., CANOBBIO, L., CANNATA, D., CUROTTO, A., BERTIRIBOLI, F., GIULIANI, L., BOCCARDO, F."LOW ACTIVITY OF CIRCADIAN CONTINUOUS FLUORODEOXYURIDINE (FUDR) CHEMOTHERAPY IN POOR-PROGNOSIS METASTATIC RENAL-CANCER". Oncology Reports 1.1 (1994): 121-123.
Chicago
MIGLIETTA, L., CANOBBIO, L., CANNATA, D., CUROTTO, A., BERTIRIBOLI, F., GIULIANI, L., BOCCARDO, F."LOW ACTIVITY OF CIRCADIAN CONTINUOUS FLUORODEOXYURIDINE (FUDR) CHEMOTHERAPY IN POOR-PROGNOSIS METASTATIC RENAL-CANCER". Oncology Reports 1, no. 1 (1994): 121-123. https://doi.org/10.3892/or.1.1.121